Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lisa Sze
Liraglutide as Add-On Therapy to Insulin in Type 2 Diabetes Mellitus: A Retrospective, Observational Study From a Daily Clinical Practice Setting in Switzerland
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Hypophyseninsuffizienz
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
Related publications
Is a Switch From Insulin Therapy to Liraglutide Possible in Japanese Type 2 Diabetes Mellitus Patients?
Journal of Clinical Medicine Research
Retrospective Analysis of an Insulin-To-Liraglutide Switch in Patients With Type 2 Diabetes Mellitus
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Type 2 Diabetes Mellitus Management: A Retrospective Study in Rural General Practice
Advances in Diabetes and Metabolism
Adherence to Liraglutide Once Daily or Exenatide Once Weekly Over a 12-Month Period Among Commercially Insured Patients With Type 2 Diabetes Mellitus: A Retrospective Observational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Superior Efficacy of Insulin Degludec/Liraglutide Versus Insulin Glargine U100 as Add-On to Sodium-Glucose Co-Transporter-2 Inhibitor Therapy: A Randomized Clinical Trial in Patients With Uncontrolled Type 2 Diabetes
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Observational Study of the Use of Insulin Glargine as Basal Therapy in Patients With Type 2 Diabetes Mellitus in Morocco
Journal of Endocrinology and Metabolism
Endocrinology
Metabolism
Diabetes
Metformin as a Safe Option to Insulin in Gestational Diabetes Mellitus: A Retrospective Study
SN Comprehensive Clinical Medicine
Cost-Utility Analysis of Liraglutide Compared With Sulphonylurea or Sitagliptin, All as Add-On to Metformin Monotherapy in Type 2 Diabetes Mellitus
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Comparative Outcomes of Basal Insulin and Oral Anti-Diabetic Agent as an Add-On to Dual Therapy in Patients With Type 2 Diabetes Mellitus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental